/Stocks
S&P 500NYSEServices-Commercial Physical & Biological Research

Iqvia Holdings Inc. IQV

Price

Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)

Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.

Results from SEC filings

Revenue$16.3B+6%FY ending Dec 31, 2025
Operating income$2.2B-1%FY ending Dec 31, 2025
Net income$1.4B-1%FY ending Dec 31, 2025
Earnings per share$7.84+5%FY ending Dec 31, 2025
Research & development$3.3M-42%FY ending Dec 31, 2015
Cash from operations$2.7B-2%FY ending Dec 31, 2025
Share buybacks$1.2B-8%FY ending Dec 31, 2025
Dividends paid$567.9M+97%FY ending Dec 31, 2012
Cash$2.0B+16%FY ending Dec 31, 2025
Long-term debt$13.9B+8%FY ending Dec 31, 2025
Shareholders' equity$6.5B+7%FY ending Dec 31, 2025
Shares outstanding170M-4%FY ending Dec 31, 2025

Insider trades

Last 12 months: 0 open-market buys ($0) and 9 sales ($51.4M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).

InsiderTradeSharesPriceValueDate
James G. BerkshireSee RemarksSold2,668$261.33$697KSep 2, 2026
W Richard StaubSee RemarksSold5,500$232.68$1.3MAug 3, 2026
Bhavik PatelSee RemarksSold1,855$235.27$436KJul 31, 2026
Ari BousbibSee Remarks, DirectorSold4 fills106,279$245.51 avg$26.1MJul 29, 2026
Eric SherbetSee RemarksSold5,000$249.16$1.2MJul 29, 2026
Keriann CherofskySee RemarksSold558$245.21$137KJul 29, 2026
Ari BousbibSee Remarks, DirectorSold36,564$222.43$8.1MDec 18, 2025
Ari BousbibSee Remarks, DirectorSold6 fills56,557$220.33 avg$12.5MOct 29, 2025
Eric SherbetSee RemarksSold4,000$219.70$879KOct 29, 2025
Other insider moves (38): pay awards, option exercises, tax withholding, gifts
InsiderTradeSharesPriceValueDate
James G. BerkshireSee RemarksReturned2,713$261.54$710KSep 2, 2026
James G. BerkshireSee RemarksOption exercise5,381$131.82$709KSep 2, 2026
Ari BousbibSee Remarks, DirectorReturned2 fills49,927$244.70 avg$12.2MJul 29, 2026
Ari BousbibSee Remarks, DirectorOption exercise156,206$78.21$12.2MJul 29, 2026
John M LeonardDirectorAward1,571––Apr 23, 2026
Colleen A GogginsDirectorAward1,571––Apr 23, 2026
John G DanhaklDirectorAward1,571––Apr 23, 2026
Carol BurtDirectorAward1,571––Apr 23, 2026
Michael J. FedockSee RemarksTax withholding123$166.94$21KFeb 13, 2026
Bernd HaasSee RemarksTax withholding20$166.94$3,339Feb 13, 2026
Ari BousbibSee Remarks, DirectorTax withholding28,399$187.49$5.3MFeb 8, 2026
Ronald E BruehlmanSee RemarksTax withholding6,801$187.49$1.3MFeb 8, 2026
Alistair GrenfellSee RemarksTax withholding5,545$187.49$1.0MFeb 8, 2026
Michael J. FedockSee RemarksTax withholding2,420$187.49$454KFeb 8, 2026
Bhavik PatelSee RemarksTax withholding1,920$187.49$360KFeb 8, 2026
Eric SherbetSee RemarksTax withholding1,915$187.49$359KFeb 8, 2026
James G. BerkshireSee RemarksTax withholding1,280$187.49$240KFeb 8, 2026
W Richard StaubSee RemarksTax withholding806$187.49$151KFeb 8, 2026
Bernd HaasSee RemarksTax withholding440$187.49$82KFeb 8, 2026
Keriann CherofskySee RemarksTax withholding415$187.49$78KFeb 8, 2026
Bernd HaasSee RemarksAward8,265––Feb 8, 2026
Alistair GrenfellSee RemarksAward11,795––Feb 8, 2026
Michael J. FedockSee RemarksAward6,735––Feb 8, 2026
Bhavik PatelSee RemarksAward4,083––Feb 8, 2026
Eric SherbetSee RemarksAward6,806––Feb 8, 2026
W Richard StaubSee RemarksAward2,722––Feb 8, 2026
Keriann CherofskySee RemarksAward1,087––Feb 8, 2026
Ronald E BruehlmanSee RemarksAward16,335––Feb 8, 2026
James G. BerkshireSee RemarksAward2,722––Feb 8, 2026
Ari BousbibSee Remarks, DirectorAward57,177––Feb 8, 2026
Michael J. FedockSee RemarksTax withholding111$187.49$21KFeb 7, 2026
Michael J. FedockSee RemarksTax withholding381$239.76$91KJan 28, 2026
Ari BousbibSee Remarks, DirectorReturned13,436$222.91$3.0MDec 18, 2025
Ari BousbibSee Remarks, DirectorOption exercise50,000$59.90$3.0MDec 18, 2025
Ari BousbibSee Remarks, DirectorReturned21,035$220.96$4.6MOct 29, 2025
Ari BousbibSee Remarks, DirectorOption exercise77,592$59.90$4.6MOct 29, 2025
Eric SherbetSee RemarksReturned6,000$219.72$1.3MOct 29, 2025
Eric SherbetSee RemarksOption exercise10,000$131.82$1.3MOct 29, 2025

Trades by members of Congress

2 members reported 1 buy and 6 sales since Feb 25, 2025. Amounts are legal ranges, not exact figures.

MemberTradeAmountTradedReportedOwner
Kevin Hern RSold$15K–$50KSep 14, 2026Sep 25, 2026Joint
Kevin Hern RSold$1,001–$15KSep 8, 2026Sep 25, 2026Child
Kevin Hern RSold$1,001–$15KSep 3, 2026Sep 25, 2026Child
Kevin Hern RSold$50K–$100KMar 16, 2026Apr 3, 2026Joint
Robert P. Bresnahan, Jr. RSold$1,001–$15KMay 15, 2025May 31, 2025Self
Robert P. Bresnahan, Jr. RBought$15K–$50KApr 8, 2025May 8, 2025Self
Robert P. Bresnahan, Jr. RSold$1,001–$15KFeb 25, 2025Mar 27, 2025Self

Latest SEC filings

All filings on SEC EDGAR ↗

About Iqvia Holdings Inc.

Business description
Industry
Services-Commercial Physical & Biological Research
Sector
Industrial Applications and Services
Headquarters
Durham, NC
Incorporated in
DE
Fiscal year ends
December 31
Exchange
NYSE
Filer size
Large accelerated filer
Formerly
Quintiles IMS Holdings, Inc., Quintiles Transnational Holdings Inc.
SEC company number (CIK)
1478242

Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.